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Abstract
The study of cross-reactivity in allergy is key to both understanding. the allergic response of many patients and providing
them with a rational treatment In the present study, protein microarrays and a co-sensitization graph approach were used in
conjunction with an allergen microarray immunoassay. This enabled us to include a wide number of proteins and a large
number of patients, and to study sensitization profiles among members of the LTP family. Fourteen LTPs from the most
frequent plant food-induced allergies in the geographical area studied were printed into a microarray specifically designed
for this research. 212 patients with fruit allergy and 117 food-tolerant pollen allergic subjects were recruited from seven
regions of Spain with different pollen profiles, and their sera were tested with allergen microarray. This approach has proven
itself to be a good tool to study cross-reactivity between members of LTP family, and could become a useful strategy to
analyze other families of allergens.
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Introduction
The fact that allergic patients sensitized to a particular allergen
can exhibit an allergic response to other agents shows that the
same IgE antibodies are able to recognize homologous allergens
from different species that share the same epitopes. This
phenomenon is known as cross-reactivity [1] and is a major
concern in allergy. The cross-reactivity allergens share the same
epitopes but can differ mainly in the identity of their primary
sequences and often in their three-dimensional structure. Under-
standing the factors and identifying the number of allergenic
sources that are involved in cross-reactivity are essential for
improving the diagnosis and treatment of allergic diseases [2,3].
To address these issues, a large number of allergens of the same
family and sera from a large number of patients are needed
because of the heterogeneity of patients’ responses. These
requirements make the study of cross-reactivity using classical
approaches difficult [4,5] and require the use of higher capacity
technologies.
The introduction of microarray techniques featuring a large
panel of purified allergens has been a major advance in the
diagnosis of allergic diseases [6,7,8]. Simultaneous measurements
of IgEs specific to many proteins from the same family using
minimal quantity of allergen and sera are now possible, allowing
many samples to be screened at reasonable cost. The huge amount
of information generated by these microarrays also demands more
powerful analytical strategies to identify associations within the
obtained data [5,6,7,8,9,10].
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In the context of graph theory, graphs, also known as networks
[7,10], represent relationships between objects and have been used
to obtain reliable information from many different biological
systems [11–16], including a network that has been established for
human diseases [17]. In particular, the graph theory has recently
been used to describe cross-reactions between antibodies in a
sandwich microarray immunoassay [17], and we use it in a similar
way here to study allergen cross-reactivity.
The family of plant lipid transfer proteins (LTPs) has been
widely studied with respect to plant food allergenic reactions and
their role in food and/or pollen cross-reactivities. Allergens from
this family have been found in most vegetable sources. Pru p 3, the
peach LTP, is the model member of this family. It is recognized by
75% of patients who suffer from peach allergy, the most frequent
plant food allergy in Spain [18,19]. Pru p 3 has been implicated in
food cross-reactivities, especially those involving fruits and nuts,
and pollens such as those of mugwort and plane [20,21].
The principal aim of this study was to study cross-reactivity in
plant foods using as models the LTP family and their recognition
by fruit-allergic patients from several regions of Spain, taking into
account the different pollen profiles in these areas. For this
purpose we used competitive cross-inhibition immunoassay and
the analytical potential of the theory of graphs.
Results
Cross-reactivity between LTPs
Considering the allergies most frequently associated with peach
sensitization in Spain [19,22,23], 14 LTPs from those foods and
pollens relevant to the study population (Table 1; see Materials
and Methods for details) were selected to construct a homemade
microarray (LTP microarray). All of the allergens were tested by
Western-blot with a polyclonal antibody against Pru p 3 (peach
LTP; 20) (Figure 1) as well as by N-terminal amino acid-
sequencing and mass spectrometry (Table 1). A comparison of the
group of fruit allergic patients with food-tolerant pollen allergic
subjects (Table 2) confirmed an association between LTP
sensitization and fruit allergy (Figure 2A). By contrast, LTP
frequencies were very similar in the group of fruit allergic patients,
regardless of their inhalant sensitization profiles.
As expected, the most prevalent LTP was Pru p 3, which was
slightly more frequently recognized by fruit-allergic patients
without pollen allergy than by those who also had respiratory
diseases, although these differences (74% versus 67%; Figure 2A)
were not statistically significant. This tendency was observed for
other allergens such as Sin a 3 (58% versus 47%) and Jug r 3 (53%
versus 43%).
Cross-reactivity between LTPs was demonstrated by inhibition
assays, selecting three allergens as models: Pru p 3 (from fruit), Art
v 3 (from pollen) and Cas s 8 (from nuts) (Figure 2B). The peach
LTP, Pru p 3, was able to completely inhibit the IgE binding of
printed LTPs, with the exception of Sin a 3. Cas s 8 and Art v 3
were more specific in their inhibition, although both were also able
to inhibit the IgE binding of the other. These data suggest that Pru
p 3 acts as the principal primary sensitizer of these types of
allergies and as the main gateway to patients’ poly-sensitization to
LTPs.
Graph-based analysis of the LTP microarray
immunoassay
In this study, graph theory has been used not only as a way to
represent LTP-microarray immunoassay data, but also to gain
insight into co-sensitization patterns of the LTP allergens in the
selected allergic population. The construction of the co-sensitiza-
tion graph associated to our LTP microarray immunoassay, shown
in Figure 3, is explained in detail in Materials and methods. In
summary, two allergens are connected by a link of the graph if at
least one serum gave a positive reaction to both allergens. The
weight of such a link is a measure of the degree of similarity
between the sera that reacted positively to each of the allergens;
the maximum weight of 1 is obtained when both allergens were
recognized by exactly the same group of reacting sera (irrespective
of the size of the group).
In this way, we were able to confirm that our co-sensitization
graph was totally connected (i.e., all allergens were interconnect-
ed). This means that at least one serum reacted positively to any
given pair of allergens, that is, there were no incompatible pairs of
co-sensitizations. Therefore, there are (20619)/2 = 190 links in the
graph, although in order to clarify the interpretation of results only
the 35 with a weight greater than 0.55 are plotted in Figure 3. The
allergens connected with the highest weights, i.e., those undergo-
Figure 1. Lipid transfer proteins (LTP) included in the homemade array were separated by SDS-PAGE and stained with Coomassie
Blue. Replicas were electrotransferred and incubated with polyclonal antibodies produced against peach LTP (dilution 1:500). The name of the
proteins corresponds to Table I.
doi:10.1371/journal.pone.0050799.g001
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ing the strongest co-sensitization, were Pru p 3 and Mal d 3 (0.89),
Mal d 3 and Cit r 3 (0.82) and the non-LTP allergens Cuc m 2 and
Pho d 2 (0.80). As expected, the lowest co-sensitizations were
found between LTP allergens and non-LTP allergens: Pers a 1 and
Tri a 14 (0.19) and Ana c 2 and Ole e 7 (0.19). The lowest co-
sensitizations between two LTP allergens were found in Par j 1
and Lyc e 3 (0.29) and Par j 1 and Sin a 3 (0.31).
The average weights shown in Table 3 and mathematically
defined in Materials and methods are a measure of the average degree
of co-sensitization that an allergen showed with the other allergens
in the graph. As expected, Pru p 3 had a very high average weight
of 0.49, meaning that it is one of the most robustly connected
nodes of the network. Bra o 3, Cit r 3 and Mal d 3 had the highest
average weights and were all above 0.5, while the non-LTP
allergens had very low average weights (all less than 0.37). The
case of the non-LTP allergens Cuc m 2 and Pho d 2 is amazing,
since these allergens are very highly co-sensitized because they
belong to the same protein family (the profilins), but their average
weight was extremely low because, as non-LTP allergens, their co-
sensitizations with the rest of the nodes were very low. Finally, it is
useful to highlight attention the case of Par j 1 and Tri a 14, the
LTP-allergens with the lowest average weight (0.36 and 0.34,
respectively).
Pattern of responses by geographical area
Subjects with fruit allergy and without any inhalant symptoms
tended to recognize more LTPs (a¯= 6) than those who were
sensitized to fruit and pollen (a¯= 5), although the difference was
not significant (Mann-Whitney U test: p= 0.0561). Curiously,
individuals from Barcelona and the Canary Islands showed a high
degree of polysensitization (a¯= 9 and a¯= 7 LTPs, respectively;
Mann-Whitney test: p = 0.0010). This was markedly higher than
those from Ourense (a¯= 3), who exhibited the lowest frequencies
for most of the LTPs analyzed.
The frequencies of recognition in most areas for Pru p 3 were
very similar, except in Ourense, where fewer than 40% of patients
recognized Pru p 3 (Figure 4). In this area, Cas s 8, the chestnut
LTP, was the most prevalent LTP with recognition of more than
80%. Considerable consumption of chestnut is typical in this area,
where patients suffer from pollen and nut allergy. With respect to
the other nut LTP, Jug r 3, people from the Canary Islands,
Barcelona and Ma´laga, but not subjects from Madrid, Bilbao or
Alicante, exhibited the highest recognition frequencies (Figure 4).
Of the pollen LTPs included in this study, only Art v 3 was
clearly associated with fruit sensitization (Figure 3; x2 = 0.001).
Areas such as Barcelona, the Canary Islands and Bilbao had the
highest frequencies of this allergen (.50%). The high frequency in
the Canary Islands could be due to the presence of this pollen, but
cross-reactivity may explain the high degree of recognition of this
pollen allergen (40%) by patients from Barcelona and Bilbao.
Figure 2. Frequency of LTP sensitization. A. Recognition frequencies of food and pollen LTPs comparing fruit allergic patients with and without
pollen sensitization (Pollen Fruit Allergy and Fruit Allergy, respectively). The recognition frequencies, shown as percentage of positive response (%),
were obtained incubating the LTP microarray with single sera from allergic patients. B. Analysis of LTP crossreactivities by inhibition assays using the
LTP microarray as solid phase and Pru p 3, Art v 3 and Cas s 8 (5, 1, 0.1, 0.01 mg/mL) as inhibitors. The inhibition percentage of the IgE binding
capacity is indicated. Means (n = 3) and SDs (bars) are represented. All tests were performed in triplicate.
doi:10.1371/journal.pone.0050799.g002
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Table 1. Purified proteins included in the LTP microarray.
Protein Family Species/Tissue N-terminal or internal peptide sequence
Accession
number Reference
Art v 3 LTP Artemisia vulgaris/pollen ALTXSDV P0C088 [20]
Bra o 3 LTP Brassica oleracea/leaf AISXGTVTSNLAPXAVYLMK Q9ZSL7 [31]
Cas s 8 LTP Castanea sativa/fruit SITXTQVSKLMPXL Q42952 [20]
Cit r 3 LTP Citrus reticulata/fruit ITXGQVTGSLAPCIAFRLTG P84161 [32]
Jug r 3 LTP Juglans regia/fruit VITXGQVASS C5H617 [33]
Lac s 1 LTP Lactuca sativa/leaf AISXGQVTANLAGXL A1E2H5 [34]
Lyc e 3 LTP Lycopersicon
esculentum/fruit
AITXGQVDAN P27056 [35]
rMal d 3 LTP Malus domestica/fruit EITCGTV Q9M5X7 [36]
Ole e 7 LTP Olea europaea/pollen APSQSTVTALLTSCVSYIDDQ P81430 [29]
rPar j 1 LTP Parietaria judaica/pollen AGLAWTSLASVAP P43217 Commercial
Pha v 3 LTP Phaseolus vulgaris/fruit K.QLSASVPGVNANNAAALPGK.C
K.CGVNVPYK.IKQLSASVPGVNANNAAALPGKC KCGVNVPYKI
Q9M5X8
(O24440)
[37]
rPru p 3 LTP Prunus persica/fruit ITCGQE Q9LED1 [36]
rSin a 3 LTP Sinapis alba/seed ALSXG EF626938 [38]
rTri a 14 LTP Triticum aestivum/wheat IDCGHVD AJ852536 [28]
*Act d 1 Cysteine
protease
Actinidia deliciosa/fruit LPSYV P00785 [39]
*Ana c 2 Cysteine
protease
Ananas comosus/pineapple
commercial
MAEYGRVYKDNDE BAA21929 Commercial
*Bet v 1 PR10 Betula verrucosa/pollen ARLFKAFILDGDNL P15494 Commercial
*Cuc m 2 Profilin Cucumis melon/fruit MSWGAYVDDHLMC AJ565931 [40]
*Pers a 1 Class I
chitinase
Persea americana/fruit EQHGR P93680 [41]
*Pho d 2 Profilin Phoenix dactylifera/pollen MSWGAYVDEHLMC AJ417566 Commercial
r recombinant protein;
*non-LTPs or control proteins included in the array are marked with an asterisk.
doi:10.1371/journal.pone.0050799.t001
Table 2. Clinical data of patients included in this study.
Fruit allergic patients Pollen-food tolerant allergic patients
Number of patients 212 117
Allergy Symptoms (%)
Rhinitis 76 87
Asthma 27 43
Oral allergy syndrome 42 0
Anaphylactic reaction 14 0
Urticaria 50 2
Angio-edema 13 0
Gastrointestinal 7 0
Others 3 0
SPT (%)3
Mugwort 40 45
Cypress 22 31
Grass 40 88
Plane 42 31
Olive 43 39
Pellitory 4 13
doi:10.1371/journal.pone.0050799.t002
The Use of Allergen Microarray in Diagnosis
PLOS ONE | www.plosone.org 4 December 2012 | Volume 7 | Issue 12 | e50799
Discussion
The analysis of the IgE binding of members of the same
allergenic family using data from large numbers of patients could
clarify recognition patterns and help us to predict cross-reactivity
in food allergy. In order to study plant food cross-reactivity, a
representative panel of LTP allergens was produced, based on the
most frequent sensitizations associated with plant food allergy in
our area [19,22,23]. The quantity of proteins required and the
number of patients led us to adopt the microarray approach to
ensure the accuracy of our study. Analysis of sensitization profiles
for allergies using microarray strategies is a powerful method, and
several research groups have obtained relevant results with this
technique [7,8,9,24–26] for a variety of pathologies. It can help us
to improve the diagnosis and treatment of allergy because many
allergens can be tested in a large number of patients in the same
assay. The lower cost and the more rapid processing of samples are
also advantages [5,7].
Lipid transfer proteins have been classified as important food
allergens and are often involved in many plant food and food/
pollen cross-reactivities [27]. In our study, Pru p 3 yielded the
highest recognition frequencies, followed by Mal d 3, Cit r 3, Bra o
3 and Sin a 3 LTP (all of them around 50%). The nut LTPs, Jug r
3 and Cas s 8, also had a very high prevalence (.40%). These
values were consistent with previously published results concerning
one of the most frequent cross-reactivities with peach observed in
Figure 3. Co-sensitization graph of LTP allergens. Each node represents one allergen (LTP, white ovals non-LTP allergens, blue squares) and the
links represent co-sensitization of one or more sera for the linked allergens. The weight of each link, between 0 and 1, measures the degree of co-
sensitization. For the sake of clarity, only the 35 links of weights greater than 0.55 of the total 190 existing links are plotted.
doi:10.1371/journal.pone.0050799.g003
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the routine clinical milieu [19,22,23]. By contrast, Tri a 14, the
wheat LTP responsible for baker’s asthma [28] was seldom
recognized in the population that we studied. The low response to
Tri a 14 suggests that this LTP is of no relevance in fruit allergy.
With respect to inhaled LTPs, Art v 3 was the only one clearly
associated with fruit allergy, in accordance with previously
described results [20]. However, the other pollen allergens, Ole
e 7 and Par j 1, gave very different recognition patterns from that
of Pru p 3. The lack of any relation between Ole e 7/Par j 1
sensitization and peach allergy has recently been described [29].
The study of LTP cross-reactivity by IgE binding inhibition
suggested that Pru p 3 was the primary sensitizing in the majority
of reactions, but not the only one. Pru p 3 was not able to fully
inhibit IgE binding of Sin a 3, or mustard LTP. This peculiarity
implies that the mustard LTP includes specific epitopes, being
other gateway into the syndrome of LTPs.
The fruit-allergic patients recognizing the largest number of
LTPs came from Barcelona and the Canary Islands. The presence
of cross-reactive pollen LTPs such as Pla a 3, from plane pollen,
and Art v 3, from mugwort pollen [20,21], may increase the
polysensitization to this allergenic family. The pollen season is
annual and may favour constant LTP sensitizations and, unlike
food, it is unavoidable.
The graph analysis also revealed strong associations between
allergens. Pru p 3 presented very high co-sensitizations with many
other allergens, suggesting that a fruit-allergic patient has a high
probability of being sensitive in turn to apple, cabbage, nut,
mustard and tangerine. However, it seems that subjects do not
easily develop allergy against green beans or lettuce in the first
stage of polysensitization. All these results are known in routine
clinical circumstances but they represent the first experimental
evidence of the syndrome of LTPs with a large number of
allergens. Therefore, our model is valuable due to its ability to
illustrate i) the degree of cross-reactivity between LTP members
and ii) the probability that patients allergic to a given LTP will be
sensitized to others. These results open up the possibility of
analyzing other routes of sensitization obtained from the graph
analysis, and therefore represent a promising line of future work.
In summary, the array approach and the application of graph
theory have proved to be useful tools in this type of study. Fruit-
allergic patients from Spain were usually polysensitized to multiple
members of the LTP family, with the sensitizations to peach,
apple, tangerine, cabbage, mustard and nuts being the most
noteworthy. LTP recognition profiles may be influenced by local
pollen patterns, especially by some pollen LTPs such as mugwort
and plane allergens.
Materials and Methods
Selection and purification of allergens
Thirteen LTPs were purified by Diaz Perales’ and Rodriguez’s
laboratories following a previously published method from natural
source or as recombinant protein in the yeast Pichia pastoris (rMal d
3, rPru p 3, rSin a 3, rTri a 14), and one, Par j 1, was produced as
recombinant in Escherichia coli by Bial Aristegui (Bilbao, Spain)
[19–21,28]. These proteins were chosen on the basis of their
previously described allergenic properties and their relationship
with peach allergy. Additional allergens were obtained to complete
the allergen array: Pru p 2.0102 (TLP, peach allergen), Act d 1
(cysteine protease, kiwi allergen), Ana c 2 (pineapple allergen), Bet
v 1 (PR10 from birch pollen), Cuc m 2 (melon fruit profilin), Pers a
1 (avocado latex-fruit allergen) and Pho d 2 (palm-pollen profilin).
All purified proteins were identified by trypsin peptide- and/or
N-terminal amino acid-sequencing and mass spectrometry
(MALDI-TOF-TOF Autoflex, Bruker, Bremen, Germany) in the
Proteomic Service of CIB, CSIC (Madrid, Spain). In addition,
every purified protein (5 mg) was visualized on Coomassie-stained
SDS-PAGE and by incubation with rabbit polyclonal antibodies to
Pru p 3 (1:500 dilution). Protein preparations were considered to
contain homogeneous molecules after adequate verification to rule
out the possibility of contamination.
Characteristics of the allergic population included
Patients from seven different regions of Spain were selected
following the same criteria. The regions were chosen based on the
regions with the highest pollen counts (Table 4, pollen count
average of the last 10 years). Fruit-allergic patients (n = 212) were
included in the study, prospectively among the adult population
(Table 2). Criteria for inclusion were: i) a consistent history of
adverse reaction to fruits, indicative of IgE-mediated allergy and ii)
giving positive results to the skin-prick test and open food
challenge, following the diagnostic algorithm recommended by
official allergy academies [30]. SPT responses were performed
following EAACI recommendations [30]. The Ethics Committee
of each hospital approved the study: the Ethic Committee of
Hospital Clinic de Barcelona; the Ethic Committee of Hospital
Universitario de la Princesa; the Ethic Committee of Hospital
Universitario de Gran Canaria Dr. Negrı´n; the Ethic Committee
of Fundacio´n Jime´nez Dı´az; the Hospital General de Alicante; the
Ethic Committee of Complexo Hospitalario de Ourense the Ethic
Committee of Hospital Civil, Ma´laga; the Ethic Committee of
Hospital de Basurto, Bilbao; the Ethic Committee of Universidad
Polite´cnica de Madrid (Spain). Patients and control volunteers also
gave their written informed consent to their participation.
Patients with seasonal rhinitis and food tolerance were included
as a control group with the following criteria: a compatible clinical
Table 3. Average weight of allergens included in the co-
sensitization graph.
Protein Family Average weight
Bra o 3 LTP 0.52
Cit r 3 LTP 0.51
Mal d 3 LTP 0.50
Jug r 3 LTP 0.50
Art v 3 LTP 0.50
Sin a 3 LTP 0.49
Pru p 3 LTP 0.49
Cas s 8 LTP 0.48
Lyc e 3 LTP 0.46
Lac s 1 LTP 0.40
Pha v 3 LTP 0.40
Pho d 2 Profilin 0.38
Ole e 7 LTP 0.37
Cuc m 2 Profilin 0.37
Par j 1 LTP 0.36
Act d 1 Cysteine protease 0.35
Tri a 14 LTP 0.34
Bet v 1 PR10 0.32
Ana c 2 Cysteine protease 0.31
Pers a 1 Class I chitinase 0.30
doi:10.1371/journal.pone.0050799.t003
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history of pollinosis confirmed by positive skin-prick tests to pollen
allergens, but without any symptoms of plant food allergy and
negative responses to food extracts by SPTs (n = 117). These
patients showed mainly positive responses to mugwort, olive and
grass pollen (Table 2). An additional group of food-tolerant
volunteers without pollinosis (n = 35; 5 per region) was recruited as
a negative control. Most of them (n = 27) were atopic suffering
from dust mite and animal dander allergies.
Production of allergen microarray and immunoassay
Purified proteins (0.25 mg/ml and 0.125 mg/ml in 1X Protein
Binding Buffer (Whatman, USA) containing 0.02% Tween 20)
were applied on epoxy-activated glass slides (TeleChem Interna-
tional, Sunnyvale, CA, USA) with 16 microarrays per slide, using a
MicroGrid II TAS arrayer (BioRobotics, Genomic Solutions, Ann
Arbor, MI, USA). Several protein concentrations (1, 0.75, 0.5,
0.25 and 0.125 mg/ml) were tested and those that resolved best
Figure 4. Recognition frequencies of food and pollen LTPs by geographical area. The recognition frequencies, shown as percentage of
positive response (%), were obtained incubating the LTP microarray with single sera from allergic patients. Only LTPs with a positive response of more
than 20% (taking all patients into account) are represented. Percentage positive responses and significant differences (p,0.05) are indicated.
doi:10.1371/journal.pone.0050799.g004
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were chosen (data not shown). Labelled pre-immune antibody was
spotted as a guide dot to support automatic image analysis.
Gaskets (TeleChem International, Sunnyvale, CA, USA) were
attached to the slides to create a barrier between the 16 arrays and
sealed to prevent evaporation. Each array well was incubated for
1 hour at room temperature with blocking solution (Sigma, St.
Louis, CO, USA) and then incubated overnight with 80 ul
undiluted serum at 4uC. To detect bound IgE antibodies, the slides
were incubated for 1 hour at room temperature with anti-human
IgE labelled with PE-DY 647 (Thermo Scientific, Rockford, IL,
USA) diluted 1:100. As a blank control, one array well per slide
was always incubated with PBS alone (Sigma, St. Louis, CO, USA)
instead of serum, and after washing, incubated with the
fluorescence secondary antibody. PBS containing 0.1% Tween
20 was used as washing solution. Three spots from the same
sample were included in each array, and two replicates of each
assay were performed (Pearson correlation = 0.83; p,0.0001).
Spots with obvious defects and those replicate spots with a
signal-to-noise ratio less than 3, as measured by GenePixTM
software (Genomics Solutions, PE, USA), were removed from the
analysis. Only those allergen spots with at least two to three
replicates fulfilling the analysis criteria were considered for
quantification. The IgE binding of each allergen spot was
calculated as the final fluorescence intensity, obtained by
subtracting the local background B from the observed value,
measured by GenePixTM software and then the fluorescence
intensity from the blank control by applying the equation: I= (F645
– B)sample – (F645 – B)blank. Fluorescence intensity levels .200 units
were considered to be positive (highest value of mean +36SD of
negative control spots, those containing only blocking solution).
Immunoinhibition assay on the LTP array
The inhibition assays were carried out as explained in the
former section for immunoassays, but with the following modifi-
cations. A pool of sera (n = 20 fruit allergic patients) was incubated
with increasing amounts of LTPs used as inhibitors (0.01, 0.1, 0.5,
1, 5 mg/mL) for 3 hours at room temperature: Pru p 3, as fruit
LTP; Cas s 8, as nut LTP; and Art v 3, as pollen LTP. The
preincubated pool was then added to the LTP array blocked with
blocking solution. All tests were performed in triplicate. The
inhibition (%) of IgE binding was determined as:
Inhibition %ð Þ~100| 1{ Fluorescence{Fluorescence100%ð Þ=½ð
Fluorescence0%{Fluorescence100%ð ÞÞ:
Fluorescence stands for the result of the immuno-inhibition
incubating the pool of sera with LTP inhibitor, Fluorescence0%
stands for the result incubating the pool of sera without LTP
inhibitor, and Fluorescence100% stands for the result incubating
LTP inhibitor in the absence of the pool of sera.
Construction of the co-sensitization graph associated
with an LTP microarray immunoassay
A weighted and undirected co-sensitization graph GA can be
associated with an LTP microarray immunoassay to study the co-
sensitization between LTPs as follows. The elements of the matrix
of fluorescence intensities I are first defined as the fluorescence Iij
obtained when the serum IgE i binds to the allergen j. Therefore,
each column of I represents the average of two microarray
immunoassays in which the same patient serum is incubated on
the LTP-microarray and revealed with fluorescently labelled anti-
human IgE (see former subsection). We call B the matrix defined
by Bij = 1 when Aij.0; otherwise, Bij = 0.
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Graphs are bipartite when they have two or more types of
nodes, and links only connect nodes of different type. Graph B
associated with matrix B is a bipartite graph. Nodes of type S
represent the NS = 329 sera and nodes of type A represent the
NA = 20 allergens (14 LTPs and 6 non-LTP allergens). Two nodes,
i (serum) and j (allergen), are connected in the bipartite graph B if
the value Bij = 1, which means that subject i has given a positive
allergic reaction to the allergen j.
We then project the bipartite graph B onto graph GA, a graph
with nodes of only one type (allergens). We call it the co-
sensitization graph and visualize it using the open source graph
visualization software GRAPHVIZ (tool NEATO). The links in
graph GA connect two allergens m and n if, in the original bipartite
graph B, these two allergens were connected to one or more
common sera. The weight wm,n of such a link between m and n
takes values from 0 to 1 and measures the similarity between the
neighbors of allergens m and n in the bipartite graph. We use the
cosine distance between two vectors to calculate wm,n:
wm,n~
Bm:Bn
DBmD:DBnD
~
PNS
k~1
Bk,m:Bk,nﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃPNS
k~1
B2k,m
: PNS
k~1
B2k,n
s
where Bm and Bn are the m- and n- columns of matrix B,
respectively. Therefore, the weight wm,n is zero, and there is no link
between m and n, when Bm and Bn have no common elements (that
is, when not even one serum has a positive reaction to both
allergens m and n), while wm,n reaches its maximum value of one
when both vectors are identical (that is, when allergens m and n are
recognized by the same group of reacting sera).
Finally, the average weight of a node is calculated as:
wl~
PNA
k~1
wl,k
NA
:
The average weight of an allergen l measures the average value of
the co-sensitizations between l and all other allergens represented
in the graph.
Statistical analysis
Fluorescence levels (in arbitrary units) obtained from each
patient’s serum were analyzed using contingency tests. Differences
in the quantitative variables were analyzed by the non-parametric
Mann-Whitney U and Kruskal-Wallis tests. Differences among
frequencies were analyzed by the Chi-square test. Values of
p,0.05 were considered significant for all tests.
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